2016 (3) 2015 (1) 2014 (3) 2013 (3) 2012 (5) 2011 (2) 2010 and before (11)


    MetaPhinder—Identifying Bacteriophage Sequences in Metagenomic Data Sets
    Jurtz VI, Villarroel J, Lund O, Larsen MV, Nielsen M
    PLoS One, 2016
    A Bacterial Analysis Platform: An Integrated System for Analysing Bacterial Whole Genome Sequencing Data for Clinical Diagnostics and Surveillance
    Thomsen MCF, Ahrenfeldt J, Cisneros JLB, Jurtz V, Larsen MV, Hasman H, Aarestrup FM, Lund O
    PLoS ONE, 2016
    HostPhinder: A Phage Host Prediction Tool
    Villarroel J, Kleinheinz KA, Jurtz V, Zschach H, Lund O, Nielsen M, Larsen MV
    Viruses, 2016
    Relevant URL


    Reads2Type: a web application for rapid microbial taxonomy identification
    Saputra D, Rasmussen S, Larsen MV, Haddad N, Sperotto MM, Aarestrup FM, Lund O, Sicheritz-Pontén T
    BMC Bioinformatics, 2015
    Relevant URL


    Improving Biotech Education through Gamified Laboritory Simulations.
    Bonde M, Makransky G, Wandall J, Larsen MV, Morsing M, Jarmer H & Sommer M
    Nature Biotechnology. 2014 Jul 8;32(7):694-7., 2014
    Benchmarking of Methods for Genomic Taxonomy.
    Larsen MV, Cosentino S, Lukjancenko O, Saputra D, Rasmussen S, Hasman H, Sicheritz-Pontén T, Aarestrup FM, Ussery DW, Lund O
    Journal of Clinical Microbiology. 2014 May;52(5):1529-39., 2014
    Applying the ResFinder and VirulenceFinder web-services for easy identification of acquired antibiotic resistance and E. coli virulence genes in bacteriophage and prophage nucleotide sequences.
    Kleinheinz KA, Joensen KG, Larsen MV
    Bacteriophage. 2014 Jan 1;4(1):e27943., 2014


    Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing.
    Zankari E, Hasman H, Kaas RS, Seyfarth AM, Agersø Y, Lund O, Larsen MV, Aarestrup FM
    Journal of Antimicrobial Chemotherapy. 2013 Apr;68(4):771-7., 2013
    Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion.
    Perez CL, Milush JM, Buggert M, Eriksson EM, Larsen MV, Liegler T, Hartogensis W, Bacchetti P, Lund O, Hecht FM, Nixon DF, Karlsson AC
    AIDS Research and Human Retroviruses 29(3):602-12 doi:10.1089/AID.2012.0171, 2013
    Bioinformatics Identification of Antigenic Peptide: Predicting the Specificity of Major MHC Class I and II Pathway Players
    Lund O, Karosiene E, Lundegaard C, Larsen MV, Nielsen M
    Methods in Molecular Biology . 960:247-60 doi:10.1007/978-1-62703-218-6_19, 2013


    Multilocus sequence typing of total-genome-sequenced bacteria.
    Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, Jelsbak L, Sicheritz-Pontén T, Ussery DW, Aarestrup FM, Lund O
    Journal of Clinical Microbiology 2012 Apr;50(4):1355-61., 2012
    Identification of a novel UTY-encoded minor histocompatibility antigen.
    Mortensen BK, Rasmussen AH, Larsen ME, Larsen MV, Lund O, Braendstrup P, Harndahl M, Rasmussen M, Buus S, Stryhn A, Vindeløv L
    Scandinavian Journal of Immunology . 2012 Aug;76(2):141-50., 2012
    The cancer exome generated by alternative mRNA splicing dilutes predicted HLA class I epitope density.
    Stranzl T, Larsen MV, Lund O, Nielsen M, Brunak S
    PLoS One. 2012;7(9):e38670, 2012
    Identification of acquired antimicrobial resistance genes
    Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV
    Journal of Antimicrobial Chemotherapy. 67(11):2640-4 doi:10.1093/jac/dks261, 2012
    Multilocus Sequence Typing of Total Genome Sequenced Bacteria
    Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H et al
    Journal of Clinical Microbiology. 2012. 50(4): 1355-1361., 2012


    Human leukocyte antigen (HLA) class I restricted epitope discovery in yellow fever and dengue viruses: importance of HLA binding strength
    Lund O, Nascimento EJ, Maciel M Jr, Nielsen M, Larsen MV, Lundegaard C, Harndahl M, Lamberth K, Buus S, Salmon J, August TJ, Marques ET Jr
    PLoS One. 2011;6(10):e26494, 2011
    Human Leukocyte Antigen (HLA) Class I Restricted Epitope Discovery in Yellow Fewer and Dengue Viruses: Importance of HLA Binding Strength.
    Lund O4, Nascimento EJM, Maciel M Jr, Nielsen M, Larsen MV, Lundegaard C, Harndahl M, Lamberth K, Buus S, Salmon J, August TJ, Marques Jr ETA
    PLoS ONE 6(10): e26494. doi:10.1371/journal.pone.0026494, 2011


    HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses
    Wang M, Larsen MV, Nielsen M, Harndahl M, Justesen S, Dziegiel MH, Buus S, Tang ST, Lund O, Claesson MH
    PLoS ONE 5(5):e10533 doi:10.1371/journal.pone.0010533, 2010
    Identification of CD8+ T cell epitopes in the West Nile virus polyprotein by reverse-immunology using NetCTL
    Larsen MV, Lelic A, Parsons R, Nielsen M, Hoof I, Lamberth K, Loeb MB, Buus S, Bramson J, Lund O
    PLoS ONE 5(9):e12697 doi:10.1371/journal.pone.0012697, 2010
    NetCTLpan: pan-specific MHC class I pathway epitope predictions
    Stranzl T, Larsen MV, Lundegaard C, Nielsen M
    Immunogenetics 62(6):357-68 doi:10.1007/s00251-010-0441-4, 2010
    Read abstract
    The Degree of Predicted Minor Histocompatibility Antigen Mismatch Correlates with Poorer Clinical Outcome of Non-myeloablative Allogeneic Hematopoietic Cell Transplantation
    Larsen ME, Kornblit B, Larsen MV, Masmas TN, Nielsen M, Thiim M, Garred P, Stryhn A, Lund O, Buus S, Vindelov L
    Biol. Blood Marrow Transplant. 16(10):1370-81 doi:10.1016/j.bbmt.2010.03.022, 2010


    Systematic Characterization of Cellular Localization and Expression Profiles of Proteins Containing MHC Ligands
    Juncker AS, Larsen MV, Weinhold N, Nielsen M, Brunak S, Lund O
    /PLoS ONE/ ; 4(10): e7448. doi:10.1371/journal.pone.0007448, 2009


    Broadly Immunogenic HLA Class I Supertype-Restricted Elite CTL Epitopes Recognized in a Diverse Population Infected with Different HIV-1 Subtypes
    Pérez CL, Larsen MV, Gustafsson R, Norström MM, Atlas A, Nixon DF, Nielsen M, Lund O, Karlsson AC
    The Journal of Immunology. 180(7):5092-100, 2008


    Prediction of T-cell Epitopes for Therapeutic and Prophylactic Vaccines
    Larsen MV
    Ph.D. thesis, 2007
    Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction
    Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M
    BMC Bioinformatics 8:424, 2007


    TAP-Independent MHC Class I Presentation
    Larsen MV, Nielsen M, Weinzierl A, Lund O
    Curr Immunol Rev, 2, 233-245, 2006
    CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening
    Wang M, Lamberth K, Harndahl M, Roder G, Stryhn A, Larsen MV, Nielsen M, Lundegaard C, Tang ST, Dziegiel MH, Rosenkvist J, Pedersen AE, Buus S, Claesson MH, Lund O
    Vaccine 25(15):2823-31, 2006


    An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport
    Larsen MV, Lundegaard C, Lamberth K, Buus S, Brunak S, Lund O, Nielsen M
    Eur. J. Immunol. 35(8):2295-303, 2005

2016 (3) 2015 (1) 2014 (3) 2013 (3) 2012 (5) 2011 (2) 2010 and before (11)